Pramel inhibitors are a class of chemical compounds designed to specifically target and inhibit the function of Pramel proteins, which are part of the Preferentially Expressed Antigen in Melanoma Like (Pramel) family. These proteins are involved in a variety of cellular processes, particularly in the regulation of gene expression and chromatin dynamics. Pramel proteins are thought to play a crucial role during early developmental stages and in the maintenance of cellular identity through their interactions with chromatin remodeling complexes. By influencing the accessibility of chromatin to transcription factors, Pramel proteins contribute to the regulation of genes involved in cell differentiation, growth, and proliferation. Inhibiting Pramel proteins disrupts these essential cellular processes, allowing researchers to explore their precise functions in gene regulation and how they contribute to maintaining cellular homeostasis.
In research, Pramel inhibitors are instrumental in uncovering the molecular mechanisms that underlie developmental biology, cellular differentiation, and epigenetic regulation. By blocking Pramel activity, scientists can investigate how inhibition affects chromatin structure and the expression of genes related to developmental pathways and cellular identity. This inhibition enables detailed studies of the downstream effects on gene networks that Pramel proteins control, offering insights into their role in critical processes such as cell fate determination, tissue development, and the maintenance of pluripotency. Additionally, Pramel inhibitors can reveal how these proteins interact with other chromatin remodelers and transcriptional regulators, helping to map the broader epigenetic landscape that governs cellular function. Through these studies, the use of Pramel inhibitors advances our understanding of chromatin biology, gene regulation, and the molecular foundations of development and differentiation, shedding light on the complex networks that maintain cellular identity and function in diverse biological systems.
SEE ALSO...
Items 11 to 12 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
ZM 336372 | 208260-29-1 | sc-202857 | 1 mg | $47.00 | 2 | |
ZM 336372 inhibits RAF kinase, affecting the phosphorylation of MEK and ERK, key proteins in the MAPK pathway. This disruption could alter the function of PRAME-like if it relies on MAPK signaling for its activities. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 is a p38 MAPK inhibitor, disrupting the phosphorylation of downstream substrates like ATF2. PRAME-like may be affected if it is involved in inflammation or stress response pathways dependent on p38 MAPK. | ||||||